These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14283294)

  • 21. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 22. INHIBITION OF FIBRINOLYTIC ACTIVITY OF PLASMIN BY VARIOUS SYNTHETIC INHIBITORS.
    MURAMATU M; ONISHI T; MAKINO S; FUJII S; YAMAMURA Y
    J Biochem; 1965 Mar; 57():450-3. PubMed ID: 14326102
    [No Abstract]   [Full Text] [Related]  

  • 23. [ON THE MODE OF ACTION OF EPSILON-AMINOCAPROIC ACID].
    RITZEL G; WUETHRICH R
    Schweiz Med Wochenschr; 1964 Feb; 94():267-71. PubMed ID: 14153727
    [No Abstract]   [Full Text] [Related]  

  • 24. EFFECTS OF EPSILON AMINOCAPROIC ACID ON COAGULATION AND FIBRINOLYTIC MECHANISMS.
    LEWIS JH; DOYLE AP
    JAMA; 1964 Apr; 188():56-63. PubMed ID: 14107215
    [No Abstract]   [Full Text] [Related]  

  • 25. EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.
    CLIFFTON EE; AGOSTINO D
    J Natl Cancer Inst; 1964 Nov; 33():753-63. PubMed ID: 14231149
    [No Abstract]   [Full Text] [Related]  

  • 26. [FIBRINOLYSIS AND EPSILON-AMINOCAPROIC ACID].
    MARCHAL G; BILSKI-PASQUIER G; SAMAMA M
    Hemostase; 1964 Mar; 4():95-101. PubMed ID: 14188681
    [No Abstract]   [Full Text] [Related]  

  • 27. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME].
    GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937
    [No Abstract]   [Full Text] [Related]  

  • 28. [HEMORRHAGIC DISORDERS IN HEMOPHILIA, WITH A SPECIAL REFERENCE TO FIBRINOLYSIS].
    KATSUMI O
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():788-97. PubMed ID: 14154696
    [No Abstract]   [Full Text] [Related]  

  • 29. [INACTIVATION BY THE LIVER OF FIBRINOLYTIC ENZYMES].
    ROUSSELOT LM; CAZES B; GROSSI CE
    Presse Med (1893); 1963 Dec; 71():2677-80. PubMed ID: 14102427
    [No Abstract]   [Full Text] [Related]  

  • 30. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

  • 31. ACUTE FIBRINOLYTIC STATES IN SURGERY.
    MCNICOL GP; DOUGLAS AS
    Proc R Soc Med; 1965 Apr; 58(4):259-61. PubMed ID: 14263735
    [No Abstract]   [Full Text] [Related]  

  • 32. EPSILON AMINO CAPROIC ACID THERAPY AS A CAUSE OF INTRARENAL OBSTRUCTION IN HAEMATURIA OF HAEMOPHILIACS.
    STARK SN; WHITE JG; LANGE RL; KRIVIT W
    Scand J Haematol; 1965; 2():99-107. PubMed ID: 14341524
    [No Abstract]   [Full Text] [Related]  

  • 33. 2 CASES OF FIBRINOLYSIS DURING SHUNT OPERATION IN CIRRHOSIS OF THE LIVER.
    LEIBA H; RAMOT B; MANY A
    Isr Med J; 1964; 23():176-80. PubMed ID: 14215370
    [No Abstract]   [Full Text] [Related]  

  • 34. [ANTIPLASMIN DRUGS].
    MATSUOKA S; OGUCHI G
    Sogo Rinsho; 1963 Oct; 12():1986-91. PubMed ID: 14092546
    [No Abstract]   [Full Text] [Related]  

  • 35. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 36. EPSILON-AMINOCAPROIC ACID (EACA).
    NAHUM LH
    Conn Med; 1964 Sep; 28():641-5. PubMed ID: 14201313
    [No Abstract]   [Full Text] [Related]  

  • 37. [60 YEARS OF FIBRINOLYSIS].
    MARCHAL G
    Hemostase; 1963; 3():101-4. PubMed ID: 14050807
    [No Abstract]   [Full Text] [Related]  

  • 38. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 39. [ELEVATION OF THE DEPRESSED THROMBOLYTIC ACTIVITY, IN ARTERIOSCLEROTICS SUBJECTED TO PROLONGED ORAL ANTICOAGULANT THERAPY, USING A DERIVATIVE OF NICOTINIC ACID].
    MORELLI AC
    Sem Med; 1963 Dec; 123():1793-8. PubMed ID: 14165315
    [No Abstract]   [Full Text] [Related]  

  • 40. ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS.
    O'CONNELL RA; GROSSI CE; ROUSSELOT LM
    Lancet; 1964 Nov; 2(7367):990-1. PubMed ID: 14201669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.